Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite
2001 ◽
Vol 28
(5-6)
◽
pp. 433-440
◽
2009 ◽
Vol 7
(4)
◽
pp. 345-360
◽
1992 ◽
Vol 106
(2)
◽
pp. 342-347
◽